Atlas Trials

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Clinical trial NCT04711850 · TERMINATED

Trial details

NCT number
NCT04711850
Sponsor
Hansa Biopharma AB
Status
TERMINATED
Study type
OBSERVATIONAL
Kidney Transplant Rejection
Start date
2021-01-20
Primary completion
2023-03-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.